Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangdong Lane Pharmaceutical Research Institute is a prominent Chinese Contract Research Organization (CRO) specializing in non-clinical drug evaluation and research services. Based in Guangzhou, the institute provides a comprehensive range of GLP-compliant services, including safety evaluation, pharmacodynamics, pharmacokinetics, and early-stage drug screening. It is notable for holding multiple international certifications, such as NMPA GLP, OECD GLP, and AAALAC accreditation, which allow its data to support regulatory submissions globally. The institute focuses on a wide array of therapeutic modalities, ranging from traditional small molecules to advanced biologics like cell and gene therapies, serving both domestic and international pharmaceutical clients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guangdong Lane Pharmaceutical Research Institute.